Biote Corp. Warrant
BTMDW
BTMDW was delisted on the 6th of July, 2023.
0 hedge funds and large institutions have $0 invested in Biote Corp. Warrant in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $32.9K → $0 (-$32.9K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$17.9K |
| 2 |
VF
Virtu Financial
New York
|
-$15K |
BTMDW Hedge Fund Activity: Q3 2023 in Review
0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Biote Corp. Warrant (BTMDW) for Q3 2023, worth a combined $0 — down 100% from $32.9K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BTMDW and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Citadel Advisors, exiting entirely with an estimated $17.9K sold.
- 0 institutional investors held Biote Corp. Warrant (BTMDW) as of Q3 2023, down from 2 in Q2 2023.
- Funds reported $0 of Biote Corp. Warrant stock for Q3 2023, down 100% quarter-over-quarter.
- 0 funds opened new Biote Corp. Warrant positions in Q3 2023 and 2 closed out, a net change of -2 holders.
- The largest Biote Corp. Warrant seller in Q3 2023 was Citadel Advisors, an estimated $17.9K sold.
Based on aggregated 13F filings for Q3 2023.